[Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia].

Sun, M L; Yang, J M; Sun, Y P; Su, G H

Sun, M L; Yang, J M; Sun, Y P; Su, G H.

Affiliation

Sun ML; Department of Oncology, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, China.
Yang JM; The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese Ministry of Health and Chinese Academy of Medical Sciences, Department of Cardiology, Qilu Hospital of Shandong University, Jinan 250012, China.
Sun YP; Department of Oncology, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, China.
Su GH; Department of Cardiology, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, China.

Zhonghua Jie He He Hu Xi Za Zhi ; 43(0): E014, 2020 Feb 16.

Article de Zh | MEDLINE | ID: mdl-32061198

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: Zh Journal: Zhonghua Jie He He Hu Xi Za Zhi Année: 2020 Type de document: Article Pays d'affiliation: Chine

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google